425: Strive and Semler Scientific Pursue Merger

Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination, as detailed in a recent communication by Strive's board member.

Summary

• Strive, Inc. and Semler Scientific, Inc. are engaged in a proposed business combination.
• The communication, a Form 425 filing, was reposted on X.com by Pierre Rochard, a Board Member of Strive, Inc., on September 25, 2025.
• The proposed transaction aims for strategic and financial benefits, including an expected impact on the combined company's future financial performance.
• Strive intends to file a Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus, to register Class A common stock to be issued.
• Semler Scientific stockholders will be asked to approve the proposed transaction.

Sentiment

Score: 6

Explanation: The filing announces a significant strategic move (merger) which is generally positive for growth potential, but it is heavily weighted with cautionary forward-looking statements and risks, leading to a neutral-to-slightly positive sentiment.

Positives

• The proposed transaction is expected to yield strategic benefits for the combined company.
• Anticipated financial benefits are projected for the combined entity.
• Management expects successful integration of the combined businesses.
• The transaction is intended to positively impact the combined company's future financial performance.

Negatives

• The proposed transaction may not close when expected or at all if conditions are not met.
• Anticipated benefits, including cost savings and strategic gains, may not be realized.
• Integration of the two companies could be more difficult, time-consuming, or costly than expected.
• The transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction will cause dilution.
• Potential for adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships exists.
• Changes in Strive's or Semler Scientific's share price may occur before closing.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized due to changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact anticipated benefits.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The outlook for the combined company includes anticipated strategic and financial benefits from the proposed transaction, with expectations for successful integration and a positive impact on future financial performance. The timing of the closing of the proposed transaction is also a key forward-looking aspect.

Management Comments

• The communication was reposted on X.com by Pierre Rochard, Board Member of Strive, Inc.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests that the proposed business combination may involve a strategic pivot or diversification into the digital asset space, which is a notable trend across various industries. This could represent a significant strategic shift for Semler Scientific, traditionally a medical device company, aligning it with broader financial technology and digital asset adoption trends.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is noted as a risk factor for the proposed transaction.

Related Party Transactions

• References to Semler Scientific's definitive proxy statement for its 2025 Annual Meeting of Stockholders for information on transactions with related persons.

Stakeholder Impact

• Shareholders of Strive will experience dilution due to the issuance of additional Class A common stock.
• Semler Scientific stockholders will need to approve the proposed transaction.
• Customers of both companies may have adverse reactions to the proposed transaction.
• Employee relationships at both companies could be affected by the announcement or completion of the transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• The companies aim to successfully integrate the combined businesses.

Key Dates

Keywords

Strive Inc, Semler Scientific Inc, Merger, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Digital Assets, Corporate Governance, Shareholder Approval